GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Cyclically Adjusted PB Ratio

CKD Bio (XKRX:063160) Cyclically Adjusted PB Ratio : 0.75 (As of Jun. 05, 2024)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Cyclically Adjusted PB Ratio?

As of today (2024-06-05), CKD Bio's current share price is ₩22350.00. CKD Bio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩29,648.00. CKD Bio's Cyclically Adjusted PB Ratio for today is 0.75.

The historical rank and industry rank for CKD Bio's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:063160' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.65   Med: 1.08   Max: 3.95
Current: 0.75

During the past years, CKD Bio's highest Cyclically Adjusted PB Ratio was 3.95. The lowest was 0.65. And the median was 1.08.

XKRX:063160's Cyclically Adjusted PB Ratio is ranked better than
79.86% of 730 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs XKRX:063160: 0.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CKD Bio's adjusted book value per share data for the three months ended in Mar. 2024 was ₩22,919.654. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩29,648.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CKD Bio Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CKD Bio's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Cyclically Adjusted PB Ratio Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 3.06 1.51 0.82 0.80

CKD Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.82 0.76 0.80 0.81

Competitive Comparison of CKD Bio's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CKD Bio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CKD Bio's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CKD Bio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CKD Bio's Cyclically Adjusted PB Ratio falls into.



CKD Bio Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CKD Bio's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=22350.00/29648
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CKD Bio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CKD Bio's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=22919.654/118.8477*118.8477
=22,919.654

Current CPI (Mar. 2024) = 118.8477.

CKD Bio Quarterly Data

Book Value per Share CPI Adj_Book
201406 22,760.817 99.353 27,226.865
201409 22,722.719 99.608 27,111.707
201412 22,622.818 99.098 27,131.424
201503 22,663.740 99.720 27,010.964
201506 22,817.351 100.050 27,104.345
201509 23,358.520 100.110 27,730.560
201512 23,649.709 100.220 28,045.435
201603 23,917.815 100.560 28,267.475
201606 24,484.644 100.790 28,871.353
201609 24,718.889 101.460 28,955.087
201612 25,095.771 101.560 29,367.612
201703 25,114.086 102.850 29,020.431
201706 25,553.704 102.610 29,597.495
201709 26,026.402 103.490 29,888.666
201712 26,373.471 102.990 30,434.279
201803 26,390.053 104.100 30,128.695
201806 26,692.248 104.130 30,464.922
201809 27,125.561 105.650 30,514.061
201812 27,416.135 104.350 31,225.152
201903 27,652.402 104.490 31,452.047
201906 28,238.842 104.880 31,999.632
201909 28,850.487 105.200 32,593.289
201912 30,892.650 105.120 34,926.944
202003 29,682.007 105.540 33,424.657
202006 30,313.240 104.870 34,353.570
202009 30,809.667 106.200 34,478.889
202012 30,759.979 105.765 34,564.732
202103 30,195.472 107.357 33,427.310
202106 30,282.176 107.579 33,454.302
202109 29,501.034 108.759 32,237.549
202112 29,437.207 109.676 31,898.789
202203 29,222.640 111.806 31,063.179
202206 28,402.392 114.083 29,588.676
202209 27,864.712 114.831 28,839.323
202212 26,941.404 115.200 27,794.430
202303 26,388.872 116.550 26,909.202
202306 25,171.728 117.140 25,538.710
202309 23,985.207 119.111 23,932.146
202312 22,425.325 118.848 22,425.325
202403 22,919.654 118.848 22,919.654

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CKD Bio  (XKRX:063160) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CKD Bio Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CKD Bio's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines